Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Keratinocytes and Fibroblasts for 2nd Degree Burns
NCT04485962Phase 2Completed
- Start
- Jan 2017
- Primary completion
- Dec 2019
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of autologous keratinocytes + fibroblasts in Thermal Burn. Primary endpoints: Number of cured patients at 1 month and Number of patients with treatment-related adverse events at 1 month. Started Jan 2017; status: completed.
02
Drugs
autologous keratinocytes + fibroblasts
03
Conditions
Thermal Burn
Beyond the preview
Go deeper on NCT04485962.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04485962.